Patent Yard Sign in
Expired Canadian patentCanada

Isoquinoline derivatives, their preparation and their use

CA 1332944 C · Owner: Novartis Ag · Inventors: Naef, Reto; Hasspacher, Klaus

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Compounds of formula I, (I), wherein R1 is hydrogen or C1_4alkyl; R2 is hydrogen and R3 is hydrogen or C1_4alkyl, or R2 and R3 together represent an additional bond as indicated by the dotted line; R4 is hydrogen C1_4alkyl or phenyl; R5 is methoxy or ethoxy; R6 is hydrogen hydroxy, C1_4alkoxy, hydroxy-(C2_4alkoxy) or (C1_4alkoxy)- (C2_4alkoxy); R7 and R8 are each independently C1_4alkoxy or (C1_4alkoxy)-(C2_4alkoxy); and R9 is hydrogen or halogen in free form or pharmaceutically acceptable salt form have, pharmaceutical utility, in particular as bronchodilators eosinophil accumulation and/or activation inhibiting agents and in the treatment or prophylactic treatment of obstructive or …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted November 8, 1994. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended November 8, 2011.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 5, 1989
GrantedNovember 8, 1994
Term endedNovember 8, 2011
Patent numberCA 1332944 C
Classification (IPC)C07D217/24 +2 more

Timeline

Timeline From CIPO dates

19901993199619992002200520082011Application filedJan 5, 1989Patent grantedNov 8, 1994Term endedNov 8, 2011

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.